[go: up one dir, main page]

WO2017021471A8 - Methods for amplifying and sequencing the genome of a hepatitis c virus - Google Patents

Methods for amplifying and sequencing the genome of a hepatitis c virus Download PDF

Info

Publication number
WO2017021471A8
WO2017021471A8 PCT/EP2016/068589 EP2016068589W WO2017021471A8 WO 2017021471 A8 WO2017021471 A8 WO 2017021471A8 EP 2016068589 W EP2016068589 W EP 2016068589W WO 2017021471 A8 WO2017021471 A8 WO 2017021471A8
Authority
WO
WIPO (PCT)
Prior art keywords
hepatitis
sequencing
amplifying
virus
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/EP2016/068589
Other languages
French (fr)
Other versions
WO2017021471A1 (en
Inventor
Sylvie Jacqueline Henriette LARRAT
Pauline TREMEAUX
Elodie SANTONI
Marie-Ange THELU
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre Hospitalier Universitaire de Grenoble
Universite Grenoble Alpes
Original Assignee
Centre Hospitalier Universitaire de Grenoble
Universite Grenoble Alpes
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre Hospitalier Universitaire de Grenoble, Universite Grenoble Alpes filed Critical Centre Hospitalier Universitaire de Grenoble
Publication of WO2017021471A1 publication Critical patent/WO2017021471A1/en
Publication of WO2017021471A8 publication Critical patent/WO2017021471A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The present invention relates to methods for amplifying and sequencing the full-length genome of a hepatitis C virus. The present invention also relates to primers and kits for amplifying and sequencing the full-length genome of a hepatitis C virus.
PCT/EP2016/068589 2015-08-03 2016-08-03 Methods for amplifying and sequencing the genome of a hepatitis c virus Ceased WO2017021471A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IBPCT/IB2015/001881 2015-08-03
PCT/IB2015/001881 WO2017021752A1 (en) 2015-08-03 2015-08-03 Methods for amplifying and sequencing the genome of a hepatitis c virus

Publications (2)

Publication Number Publication Date
WO2017021471A1 WO2017021471A1 (en) 2017-02-09
WO2017021471A8 true WO2017021471A8 (en) 2017-09-21

Family

ID=54540129

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/IB2015/001881 Ceased WO2017021752A1 (en) 2015-08-03 2015-08-03 Methods for amplifying and sequencing the genome of a hepatitis c virus
PCT/EP2016/068589 Ceased WO2017021471A1 (en) 2015-08-03 2016-08-03 Methods for amplifying and sequencing the genome of a hepatitis c virus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/IB2015/001881 Ceased WO2017021752A1 (en) 2015-08-03 2015-08-03 Methods for amplifying and sequencing the genome of a hepatitis c virus

Country Status (1)

Country Link
WO (2) WO2017021752A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110867207B (en) * 2019-11-26 2021-07-30 北京橡鑫生物科技有限公司 Evaluation method and evaluation device for validating NGS variant detection methods
CN111187813B (en) * 2020-02-20 2020-12-04 予果生物科技（北京）有限公司 High-throughput sequencing detection method for pathogenic microorganisms with full-process quality control
CN113151595B (en) * 2021-03-31 2024-02-06 广州金域医学检验中心有限公司 Amplification primer for detecting HCV6 type drug-resistant mutant gene, detection method and application
CN112961942B (en) * 2021-03-31 2024-02-02 广州金域医学检验中心有限公司 Amplification primer for detecting HCV 2a subtype drug-resistant mutant gene, detection method and application
CN113025756B (en) * 2021-03-31 2024-02-06 广州金域医学检验中心有限公司 Detection method for detecting HCV type 1 drug-resistant mutant gene and application

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8575327B2 (en) * 2003-06-12 2013-11-05 Alnylam Pharmaceuticals, Inc. Conserved HBV and HCV sequences useful for gene silencing
WO2013040060A2 (en) * 2011-09-12 2013-03-21 Pathogenica, Inc. Nucleic acids for multiplex detection of hepatitis c virus

Also Published As

Publication number Publication date
WO2017021752A1 (en) 2017-02-09
WO2017021471A1 (en) 2017-02-09

Similar Documents

Publication Publication Date Title
HK1257295A1 (en) Compositions and methods for immunooncology
WO2015112896A3 (en) Methods and compositions for sequences guiding cas9 targeting
EP3283472A4 (en) Hepatitis b viral assembly effectors
EP3286338A4 (en) Amplification with primers of limited nucleotide composition
HK1258205A1 (en) Compositions and methods for the treatment of hemoglobinopathies
HK1243714A1 (en) Methods of preparing substituted nucleoside analogs
HK1245800A1 (en) Substituted nucleosides, nucleotides and analogs thereof
EP3507367A4 (en) Locked nucleic acid cyclic dinucleotide compounds and uses thereof
HK1225758A1 (en) Amplicon preparation and sequencing on solid supports
WO2015196128A3 (en) Alternative nucleic acid molecules and uses thereof
WO2015196130A3 (en) Alternative nucleic acid molecules and uses thereof
HK1253403A1 (en) Genome editing vectors
EP3271849A4 (en) Detection of genome editing
EP3242938A4 (en) Detection of genome editing
WO2016099982A3 (en) Phosphoramidates for the treatment of hepatitis b virus
DK3512863T3 (en) 2β-substituted-N6-substituted purine nucleotides for the treatment of RNA virus
LT3577124T (en) NUCLEOTIDE HEMISULFATE SALT FOR THE TREATMENT OF HEPATITIS C VIRUS
WO2017021471A8 (en) Methods for amplifying and sequencing the genome of a hepatitis c virus
HK1250480A1 (en) Compositions and methods for the treatment of hbv infection
IL254243A0 (en) Inhibitors of hepatitis c virus polymerase
HK1249046A1 (en) Methods of treating hepatitis b virus
SI3400225T1 (en) Pentanoic acids substituted by pyrrolo-(2-3,b)pyrimidine-pyridines for the treatment of influenza viral infections
HK1252343A1 (en) Compositions and methods for the treatment of viral infection
EP3250553A4 (en) Compositions and methods for inhibiting viral infection
EP3400007A4 (en) Orthomyxo-like virus of tilapia

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16750735

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16750735

Country of ref document: EP

Kind code of ref document: A1